Bit.bio specializes in cell coding technology, which enables the production of consistent and functional human cells for research, drug discovery, and cell therapy. By applying computational principles to biology, they have developed a scalable platform capable of generating batches of every human cell. This breakthrough has the potential to revolutionize medicine by allowing researchers to work with cells that are actually affected by human diseases, rather than inappropriate models. Additionally, the platform serves as the foundation for a new generation of cell and tissue therapies. Bit.bio has assembled a team of experts in stem cells, cellular reprogramming, mathematical modeling, and cell therapy, and collaboration is at the core of their approach. Their technology democratizes access to consistent and efficient human cells, improving research, drug discovery, and the application of cell therapies.